Abingdon Health Plc (LON:ABDX – Get Free Report)’s share price shot up 9.7% during trading on Tuesday . The company traded as high as GBX 8.50 ($0.11) and last traded at GBX 7.95 ($0.10). 435,852 shares changed hands during mid-day trading, an increase of 101% from the average session volume of 216,733 shares. The stock had previously closed at GBX 7.25 ($0.09).
Abingdon Health Stock Down 2.2 %
The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95. The firm’s 50-day simple moving average is GBX 7.84 and its 200 day simple moving average is GBX 9.33. The company has a market capitalization of £14.37 million, a PE ratio of -899.00 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Featured Stories
- Five stocks we like better than Abingdon Health
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Stock Buybacks Outperform Dividends: Here’s the Key Advantage
- Why Invest in 5G? How to Invest in 5G Stocks
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Are Growth Stocks and Investing in Them
- Why Now Is the Ultimate Time to Invest in Oil Stocks
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
